Výsledky vyhledávání - Stephen J. Schuster

Upřesnit hledání
  1. 1
    Bispecific antibodies for the treatment of lymphomas: Promises and challenges

    Bispecific antibodies for the treatment of lymphomas: Promises and challenges Autor Stephen J. Schuster

    Vydáno 2021
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy

    Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy Autor Elise A. Chong, Marco Ruella, Stephen J. Schuster

    Vydáno 2021
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases

    Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases Autor Guillermo Garc�a-Manero, Stephen J. Schuster, Herbert Patrick, J. J. Martinez

    Vydáno 1999
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte)

    BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte) Autor Elise A. Chong, Lindsey E. Roeker, Mazyar Shadman, Matthew S. Davids, Stephen J. Schuster, Anthony R. Mato

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Outcomes of patients with relapsed/refractory diffuse large B‐cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era

    Outcomes of patients with relapsed/refractory diffuse large B‐cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era Autor Sarah Nagle, Kaitlin M. Woo, Stephen J. Schuster, Sunita D. Nasta, Edward A. Stadtmauer, Rosemarie Mick, Jakub Svoboda

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia

    Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia Autor Kai‐Uwe Eckardt, Stephen T. Koury, Chorh Chuan Tan, Stephen J. Schuster, Brigitte Kaissling, Peter J. Ratcliffe, Armin Kurtz

    Vydáno 1993
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Efficacy and safety of <scp>CD19</scp>‐directed <scp>CAR‐T</scp> cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the <scp>JULIET</scp>, <scp>ZUMA</scp>‐1, and <scp>TRANSCEND</scp> trials

    Efficacy and safety of <scp>CD19</scp>‐directed <scp>CAR‐T</scp> cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the <scp>JULIET<... Autor Jason R. Westin, Marie José Kersten, Gilles Salles, Jeremy S. Abramson, Stephen J. Schuster, Frederick L. Locke, Charalambos Andreadis

    Vydáno 2021
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Comparable outcomes in chronic lymphocytic leukaemia (<scp>CLL</scp>) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study

    Comparable outcomes in chronic lymphocytic leukaemia (<scp>CLL</scp>) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study Autor Anthony R. Mato, Colleen Timlin, Chaitra S. Ujjani, Alan P Skarbnik, Christina Howlett, Rahul Banerjee, Chadi Nabhan, Stephen J. Schuster

    Vydáno 2017
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

    Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial Autor Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch, Junlong Li, James Signorovitch, Vadim Romanov, Frederick L. Locke, David G. Maloney

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

    Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial Autor Richard T. Maziarz, Stephen J. Schuster, Vadim Romanov, Elisha S. Rusch, Junlong Li, James Signorovitch, David G. Maloney, Frederick L. Locke

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Durable complete responses from therapy with combined epratuzumab and rituximab

    Durable complete responses from therapy with combined epratuzumab and rituximab Autor John P. Leonard, Stephen J. Schuster, Christos Emmanouilides, Félix Couture, Nick Teoh, William A. Wegener, Morton Coleman, David M. Goldenberg

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Combined lenalidomide, low‐dose dexamethasone, and rituximab achieves durable responses in rituximab‐resistant indolent and mantle cell lymphomas

    Combined lenalidomide, low‐dose dexamethasone, and rituximab achieves durable responses in rituximab‐resistant indolent and mantle cell lymphomas Autor Tahamtan Ahmadi, Elise A. Chong, Amanda Gordon, Nicole A. Aqui, Sunita D. Nasta, Jakub Svoboda, Anthony R. Mato, Stephen J. Schuster

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas

    Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas Autor Elise A. Chong, Tahamtan Ahmadi, Nicole A. Aqui, Jakub Svoboda, Sunita D. Nasta, Anthony R. Mato, Kristy M. Walsh, Stephen J. Schuster

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    PD-1 blockade modulates chimeric antigen receptor (CAR)–modified T cells: refueling the CAR

    PD-1 blockade modulates chimeric antigen receptor (CAR)–modified T cells: refueling the CAR Autor Elise A. Chong, J. Joseph Melenhorst, Simon F. Lacey, David E Ambrose, Vanessa Gonzalez, Bruce L. Levine, Carl H. June, Stephen J. Schuster

    Vydáno 2016
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  15. 15
    High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic Transplantation

    High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic Transplantation Autor Elisabeth A. Hagen, H Stern, David Porter, Kathleen M. Duffy, Karen Foley, Selina M. Luger, Stephen J. Schuster, Edward A. Stadtmauer, Mindy G. Schuster

    Vydáno 2003
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy

    Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy Autor Elise A. Chong, Cécile Alanio, Jakub Svoboda, Sunita D. Nasta, Daniel J. Landsburg, Simon F. Lacey, Marco Ruella, Siddharth Bhattacharyya, E. John Wherry, Stephen J. Schuster

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1

    REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1 Autor Donald E. Tsai, Christine Hardy, John E. Tomaszewski, Robert M. Kotloff, Kimberly M. Oltoff, Bradley G. Somer, Stephen J. Schuster, David Porter, Kathleen T. Montone, Edward A. Stadtmauer

    Vydáno 2001
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

    Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004) Autor Michael Wang, Stephen J. Schuster, Tycel Phillips, Izidore S. Lossos, André Goy, Simon Rule, Mehdi Hamadani, Nilanjan Ghosh, Craig B. Reeder, Evelyn Barnett, Marie-Laure Casadebaig Bravo, Peter Martin

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma

    Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma Autor Rebecca L. Olin, Dan T. Vogl, David Porter, Selina M. Luger, Stephen J. Schuster, Donald E. Tsai, Don L. Siegel, Richard J. Cook, Patricia Mangan, K. Cunningham, Edward A. Stadtmauer

    Vydáno 2008
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results

    Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results Autor Franck Morschhauser, John P. Leonard, Luis Fayad, Bertrand Coiffier, Marie-Odile Petillon, Morton Coleman, Stephen J. Schuster, Martin J.S. Dyer, Heather Horne, Nick Teoh, William A. Wegener, David M. Goldenberg

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: